Viatris Buys Two Eye Specialists, Setting The Stage For ‘Phase Two’ Of Its Growth Plan

Acquisitions Could Add $1bn To Net Sales By 2028

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.